SCHEMBL9615905

SCHEMBL9615905

CCC(C)Cc1ccc(S(=O)(=O)O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
ALDH1A1 P00352 5/20 0.41
TSHR P16473 3/20 0.41
NT5E P21589 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
CA2 P00918 3/20 0.39
CA1 P00915 2/20 0.39
CA7 P43166 2/20 0.39
CA14 Q9ULX7 2/20 0.39
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
GAA P10253 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18636107 1.00 LMNA (0.42) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL17277069 0.86 CA2 (0.43) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL9568574 0.83 LMNA (0.43) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL6266176 0.82 ALDH1A1 (0.58) LMNAALDH1A1TSHRSMN1; SMN2CA2
SCHEMBL6681080 0.82 GAA (0.41) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL20257140 0.81 CA2 (0.60) SMN1; SMN2CA2CA1CA7CA14
SCHEMBL22069625 0.81 LMNA (0.38) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL15641683 0.80 TDP1 (0.44) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL775989 0.79 LMNA (0.43) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL19457401 0.79 LMNA (0.43) LMNAALDH1A1TSHRNT5ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4175375-A None JP disclosed
US-20230293576-A1 ANTIVIRAL POLYMERS THE UNIVERSITY OF MANCHESTER (GB) 2023-09-21 US disclosed
US-20190217648-A1 THERMAL TRANSFER RECORDING SHEET CANON KABUSHIKI KAISHA (JP) 2019-07-18 US disclosed
JP-H04175375-A THERMOSETTING COMPOSITION NIPPON OIL & FATS CO LTD 1992-06-23 JP disclosed
US-4695131-A FLUORINATED AROMATIC COMPOUNDS; INSTRUMENT PANELS, AUTOMOBILES QINETIQ LIMITED (GB) 1987-09-22 US disclosed
EP-0117631-B1 DISUBSTITUTED ETHANES AND THEIR USE IN LIQUID CRYSTAL MATERIALS AND DEVICES The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) 1987-04-29 EP disclosed
EP-0115429-B1 BIPHENYLS AND THEIR USE IN THE PRODUCTION OF LIQUID CRYSTAL COMPOUNDS The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) 1987-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293576-A1 ANTIVIRAL POLYMERS MAVS, EIF2AK2, ZC3HAV1 LMNA 1691/4885ALDH1A1 3162/4885TSHR 4791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.